80 FR 52511 - Manufacturer of Controlled Substances Registration: Johnson Matthey Pharmaceutical Materials, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 168 (August 31, 2015)

Page Range52511-52511
FR Document2015-21521

Johnson Matthey Pharmaceutical Materials, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey Pharmaceutical Materials, Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 80 Issue 168 (Monday, August 31, 2015)
[Federal Register Volume 80, Number 168 (Monday, August 31, 2015)]
[Notices]
[Page 52511]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-21521]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Johnson 
Matthey Pharmaceutical Materials, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey Pharmaceutical Materials, Inc. applied to be 
registered as a manufacturer of certain basic classes of controlled 
substances. The Drug Enforcement Administration (DEA) grants Johnson 
Matthey Pharmaceutical Materials, Inc. registration as a manufacturer 
of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015, 80 FR 22559, 
Johnson Matthey Pharmaceutical Materials, Inc., 25 Patton Road, Devens, 
Massachusetts 01434 applied to be registered as a manufacturer of 
certain basic classes of controlled substances. No comments or 
objections were submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Johnson Matthey Pharmaceutical 
Materials, Inc. to manufacture the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Nabilone (7379)............................  II
Hydrocodone (9193).........................  II
Alfentanil (9737)..........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substances in bulk and to conduct 
analytical testing in support of the company's primary manufacturing 
facility in West Deptford, New Jersey. The controlled substances 
manufactured in bulk at this facility will be distributed to its 
company's customers.

    Dated: August 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-21521 Filed 8-28-15; 8:45 am]
BILLING CODE 4410-09-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of registration.
FR Citation80 FR 52511 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR